ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune ...

2h ago, source: Business Wire

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed ...

Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday?

on MSN ago, source:

Alpine Immune Sciences Inc (NASDAQ:ALPN) is reportedly considering strategic options, including a potential sale, following ...

Vertex Pharma’s $4.9 billion takeover of Alpine Immune gives it access to a potential billion-dollar franchise, analyst says

on MSN ago, source:

Vertex Pharmaceuticals Inc.’s $4.9 billion acquisition of Alpine Immune Sciences Inc. makes strategic sense and will bolster ...

Alpine's data room was the most exclusive club in biotech. Then Vertex became the VIP

3d ago, source: FierceBiotech

After Alpine Immune Sciences presented initial data for the kidney disease therapy povetacicept at a conference in November ...

ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders

15d ago, source: Business Wire

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Alpine Immune Sciences, Inc. (NASDAQ: ...

Alpine Immune Is Weighing Options After Takeover Interest

16d ago, source: Bloomberg L.P.

Alpine Immune Sciences Inc., a clinical-stage biotechnology company developing a treatment for inflammatory kidney diseases, is weighing options including a potential sale after attracting ...

Alpine Immune Sciences Inc (34LA.SG)

9d ago, source: Yahoo Finance

SEATTLE, April 10, 2024--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory ...

Alpine Immune Sciences, Inc. (ALPN)

4d ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Alpine Immune Sciences Inc

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Alpine Immune Sciences Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...